Summary of Study ST002944

This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR001831. The data can be accessed directly via it's Project DOI: 10.21228/M81Q73 This work is supported by NIH grant, U2C- DK119886.

See: https://www.metabolomicsworkbench.org/about/howtocite.php

This study contains a large results data set and is not available in the mwTab file. It is only available for download via FTP as data file(s) here.

Show all samples  |  Perform analysis on untargeted data  
Download mwTab file (text)   |  Download mwTab file(JSON)   |  Download data files (Contains raw data)
Study IDST002944
Study TitleLongitudinal polar fecal metabolomics of mice undergoing sensitization to beta-lactoglobulin
Study Type(un)targeted MS
Study SummaryThis study is part of a multi-part study, including a. longitudinal polar fecal metabolomics of mice undergoing sensitization to beta-lactoglobulin b. polar fecal metabolomics of a patient cohort c. fecal lipidomics of a patient cohort d. polar urinary metabolomics of a patient cohort e. polar metabolomics of in vitro digestions This specific part is part a. longitudinal polar fecal metabolomics of mice undergoing sensitization to beta-lactoglobulin
Institute
Ghent University
DepartmentDepartment of Translational Physiology, Infectiology and Public Health
LaboratoryLaboratory for Integrative Metabolomics
Last NameDe Paepe
First NameEllen
AddressSalisburylaan 133, 9820 Merelbeke, Belgium
EmailEllen.DePaepe@UGent.be
Phone0032479081098
Submit Date2023-07-06
Raw Data AvailableYes
Raw Data File Type(s)raw(Thermo)
Analysis Type DetailLC-MS
Release Date2023-11-01
Release Version1
Ellen De Paepe Ellen De Paepe
https://dx.doi.org/10.21228/M81Q73
ftp://www.metabolomicsworkbench.org/Studies/ application/zip

Select appropriate tab below to view additional metadata details:


Project:

Project ID:PR001831
Project DOI:doi: 10.21228/M81Q73
Project Title:Integrated gut metabolome and microbiome fingerprinting reveals that dysbiosis precedes allergic inflammation in IgE-mediated pediatric cow’s milk allergy
Project Type:(un)targeted MS
Project Summary:Background: IgE-mediated cow’s milk allergy (IgE-CMA) is one of the first allergies to arise in early childhood and may result from exposure to various milk allergens, of which β-lactoglobulin (BLG) and casein are the most important. Understanding the underlying mechanisms behind IgE-CMA is imperative for the discovery of novel biomarkers and the design of innovative treatment and prevention strategies. Methods: We report a longitudinal in vivo murine model, in which 2 mice strains (BALB/c and C57Bl/6) were sensitized to BLG using either cholera toxin or an oil emulsion (n=6 per group). After sensitization, mice were challenged orally, their clinical signs monitored, antibody (IgE and IgG1) and cytokine levels (IL-4 and IFN-γ) measured, and fecal samples subjected to metabolomics. The results of the murine models were further supported by fecal microbiome-metabolome data from our population of IgE-CMA (n=24) and healthy (n=23) children (Trial: NCT04249973), on which polar metabolomics, lipidomics and 16S rRNA metasequencing were performed. In vitro gastrointestinal digestions and multi-omics corroborated the microbial origin of proposed metabolic changes. Results: During sensitization, we observed multiple microbially derived metabolic alterations, most importantly bile acid, energy and tryptophan metabolites, that preceded allergic inflammation. The latter was reflected in a disturbed sphingolipid metabolism. We confirmed microbial dysbiosis, and its causal effect on metabolic alterations in our patient cohort, which was accompanied by metabolic signatures of low-grade inflammation. Conclusion: Our results indicate that gut dysbiosis precedes allergic inflammation and nurtures a chronic low-grade inflammation in children on elimination diets, opening important new opportunities for future prevention and treatment strategies.
Institute:Ghent University
Department:Translational Physiology, Infectiology and Public Health
Laboratory:Laboratory for Integrative Metabolomics
Last Name:De Paepe
First Name:Ellen
Address:Salisburylaan 133, Merelbeke, Oost-Vlaanderen, 9820, Belgium
Email:Ellen.DePaepe@UGent.be
Phone:0032479081098
Funding Source:Fonds Wetenschappelijk Onderzoek

Subject:

Subject ID:SU003057
Subject Type:Mammal
Subject Species:Mus musculus
Taxonomy ID:10090
Genotype Strain:BALB/c and C57Bl/6
Age Or Age Range:3-10 weeks
Gender:Female
Animal Animal Supplier:Charles River
Animal Housing:SPF
Animal Feed:Sniff
Animal Water:Ad libitum

Factors:

Subject type: Mammal; Subject species: Mus musculus (Factor headings shown in green)

mb_sample_id local_sample_id Strain treatment week
SA320431S_21_0066_35B6 1A Wk 1
SA320432S_21_0066_191B6 1A Wk 4
SA320433S_21_0066_179B6 1B Wk 4
SA320434S_21_0066_129B6 1C Wk 1
SA320435S_21_0066_205B6 1C Wk 4
SA320436S_21_0066_75B6 1D Wk 4
SA320437S_21_0066_125B6 1E Wk 1
SA320438S_21_0066_34B6 1E Wk 4
SA320439S_21_0066_31B6 1F Wk 1
SA320440S_21_0066_124B6 1F Wk 4
SA320441S_21_0066_16B6 1W Wk 1
SA320442S_21_0066_190B6 1X Wk 1
SA320443S_21_0066_273B6 1X Wk 7
SA320444S_21_0066_245B6 1Y Wk 7
SA320445S_21_0066_308B6 1Z Wk 1
SA320446S_21_0066_236B6 1Z Wk 7
SA320447S_21_0066_267B6 2A Wk 1
SA320448S_21_0066_93B6 2A Wk 4
SA320449S_21_0066_195B6 2B Wk 4
SA320450S_21_0066_211B6 2C Wk 1
SA320451S_21_0066_193B6 2C Wk 4
SA320452S_21_0066_8B6 2D Wk 4
SA320453S_21_0066_86B6 2E Wk 1
SA320454S_21_0066_158B6 2E Wk 4
SA320455S_21_0066_23B6 2F Wk 4
SA320456S_21_0066_126B6 2W Wk 1
SA320457S_21_0066_263B6 2X Wk 1
SA320458S_21_0066_244B6 2X Wk 7
SA320459S_21_0066_207B6 2Y Wk 7
SA320460S_21_0066_260B6 2Z Wk 1
SA320461S_21_0066_254B6 3A Wk 1
SA320462S_21_0066_132B6 3A Wk 4
SA320463S_21_0066_73B6 3B Wk 4
SA320464S_21_0066_60B6 3C Wk 1
SA320465S_21_0066_222B6 3C Wk 4
SA320466S_21_0066_21B6 3D Wk 4
SA320467S_21_0066_264B6 3E Wk 4
SA320468S_21_0066_282B6 3F Wk 4
SA320469S_21_0066_116B6 3W Wk 1
SA320470S_21_0066_294B6 3W Wk 7
SA320471S_21_0066_271B6 3X Wk 1
SA320472S_21_0066_262B6 3X Wk 7
SA320473S_21_0066_118B6 3Z Wk 1
SA320474S_21_0066_41B6 3Z Wk 7
SA320475S_21_0066_151B6 4A Wk 4
SA320476S_21_0066_56B6 4B Wk 1
SA320477S_21_0066_71B6 4B Wk 4
SA320478S_21_0066_202B6 4C Wk 1
SA320479S_21_0066_103B6 4C Wk 4
SA320480S_21_0066_198B6 4D Wk 1
SA320481S_21_0066_172B6 4D Wk 4
SA320482S_21_0066_268B6 4E Wk 1
SA320483S_21_0066_47B6 4E Wk 4
SA320484S_21_0066_229B6 4F Wk 4
SA320485S_21_0066_5B6 4W Wk 1
SA320486S_21_0066_286B6 4W Wk 7
SA320487S_21_0066_261B6 4X Wk 1
SA320488S_21_0066_12B6 4X Wk 7
SA320489S_21_0066_168B6 4Y Wk 1
SA320490S_21_0066_13B6 4Y Wk 7
SA320491S_21_0066_288B6 4Z Wk 7
SA320492S_21_0066_252B6 5A Wk 1
SA320493S_21_0066_233B6 5A Wk 4
SA320494S_21_0066_62B6 5B Wk 1
SA320495S_21_0066_184B6 5B Wk 4
SA320496S_21_0066_102B6 5C Wk 1
SA320497S_21_0066_101B6 5C Wk 4
SA320498S_21_0066_55B6 5D Wk 1
SA320499S_21_0066_20B6 5D Wk 4
SA320500S_21_0066_58B6 5E Wk 1
SA320501S_21_0066_209B6 5E Wk 4
SA320502S_21_0066_50B6 5F Wk 1
SA320503S_21_0066_206B6 5F Wk 4
SA320504S_21_0066_274B6 5W Wk 1
SA320505S_21_0066_311B6 5W Wk 7
SA320506S_21_0066_36B6 5X Wk 1
SA320507S_21_0066_174B6 5X Wk 7
SA320508S_21_0066_37B6 5Y Wk 1
SA320509S_21_0066_306B6 5Y Wk 7
SA320510S_21_0066_287B6 5Z Wk 1
SA320511S_21_0066_139B6 5Z Wk 7
SA320512S_21_0066_61B6 6A Wk 1
SA320513S_21_0066_53B6 6A Wk 4
SA320514S_21_0066_80B6 6B Wk 4
SA320515S_21_0066_18B6 6C Wk 1
SA320516S_21_0066_266B6 6C Wk 4
SA320517S_21_0066_128B6 6D Wk 1
SA320518S_21_0066_28B6 6D Wk 4
SA320519S_21_0066_279B6 6E Wk 1
SA320520S_21_0066_57B6 6E Wk 4
SA320521S_21_0066_51B6 6F Wk 1
SA320522S_21_0066_214B6 6F Wk 4
SA320523S_21_0066_54B6 6W Wk 1
SA320524S_21_0066_199B6 6W Wk 7
SA320525S_21_0066_32B6 6X Wk 1
SA320526S_21_0066_68B6 6X Wk 7
SA320527S_21_0066_215B6 6Y Wk 1
SA320528S_21_0066_105B6 6Y Wk 7
SA320529S_21_0066_304B6 6Z Wk 1
SA320530S_21_0066_224B6 6Z Wk 7
Showing page 1 of 4     Results:    1  2  3  4  Next     Showing results 1 to 100 of 329

Collection:

Collection ID:CO003050
Collection Summary:Fecal samples were collected on different timepoints during sensitization of the mice. Samples were freeze-dried within one week after collection and stored at -80° awaiting analysis
Sample Type:Feces
Collection Method:Spontaneous defecation
Collection Frequency:1x week
Storage Conditions:-80℃

Treatment:

Treatment ID:TR003066
Treatment Summary:Two different mice strains and two different protocols were tested: BALB/c (BC) mice and C57Bl/6 (B6) mice. The first sensitization protocol was based on Adel-Patient et al., in which 4-week-old mice received oral gavages containing ß-lactoglobulin (BLG) and cholera toxin (CT) once a week for 6 weeks 20 (treatment W), the control groups received either BLG in PBS (X), CT in PBS (Y) or PBS alone (Z). The second protocol was adapted from Shindo et al. and included intragastrical administration of BLG in PBS or oil emulsion, followed by intraperitoneal injection of sodium salicylate (SA). The latter protocol was performed 5x a week for 3 weeks. Group A received BLG in PBS + SA, group B BLG in oil + SA, group C BLG in PBS + PBS, group D BLG in oil + PBS, group E and F were vehicle controls with group E receiving PBS + SA, and group F oil + SA
Treatment Compound:Beta-lactoglobulin, cholera toxin
Treatment Route:oral gavage, intraperitoneal injection
Treatment Dose:1 mg ß-lactoglobulin (BLG) per g body weight mixed with 10 µg of cholera toxin (CT) in 0.1 mL PBS, or 1 mg BLG in 0.1 mL individual antigen solution (vehicle), which was either PBS or an oil emulsion (saline, linoleic acid, and lecithin at 5:4:1 by volume). Intraperitoneal administration of 0.1 mL PBS or PBS containing 0.2 mg sodium salicylate (SA)
Treatment Doseduration:3 or 7 weeks
Treatment Vehicle:PBS or oil emulsion
Animal Anesthesia:CO
Animal Fasting:Evening before antigen challenge
Animal Endp Euthanasia:cervical dislocation
Animal Endp Clinical Signs:severe anaphylaxis

Sample Preparation:

Sampleprep ID:SP003063
Sampleprep Summary:To extract the polar fecal metabolome, 200 mg of lyophilized homogenized feces was dissolved in 4 mL of ultrapure water, after the addition of 100 mL ISTD mixture (25 ng mL&1 of Dvaline- d8 and L-alanine-d3). Subsequent to 30 s of thorough vortexing, 1 mL of an ice-cold methanol and ultrapure water (80:20, v/ v) mixture was added. The supernatant of the solid-liquid extraction was collected after 1 min of vortexing and 10 min of rotation, followed by a 10-min centrifugation step (13 300 x g, at 4 %C). Next, the extract was passed over a polyamide filter (diameter of 25mm and pore size of 0.45 mm) (Machery-Nagel, Düren, Germany), diluted (1:3) with ultrapure water and transferred to a glass HPLCvial.
Processing Storage Conditions:-80℃
Sample Spiking:Internal standard

Combined analysis:

Analysis ID AN004829
Analysis type MS
Chromatography type Reversed phase
Chromatography system Thermo Dionex Ultimate 3000
Column Waters ACQUITY UPLC HSS T3 (150 x 2.1mm,1.8um)
MS Type ESI
MS instrument type Orbitrap
MS instrument name Thermo Q Exactive Orbitrap
Ion Mode UNSPECIFIED
Units a.u.

Chromatography:

Chromatography ID:CH003649
Instrument Name:Thermo Dionex Ultimate 3000
Column Name:Waters ACQUITY UPLC HSS T3 (150 x 2.1mm,1.8um)
Column Temperature:45
Flow Gradient:A gradient profile with following proportions (v/v) of solvent A was applied: 0e1.5 min at 98%, 1.5e7.0 min from 98% to 75%, 7.0e8.0 min from 75% to 40%, 8.0e12.0 min from 40% to 5%, 12.0e14.0 min at 5%, 14.0e14.1 min from 5 to 98%, followed by 4.0 min of re-equilibration.
Flow Rate:0.4 mL/min
Internal Standard:L-alanine-d3, D-valine-d8
Sample Injection:10 uL
Solvent A:100% water; 0.1% formic acid
Solvent B:100% acetonitrile; 0.1% formic acid
Chromatography Type:Reversed phase

MS:

MS ID:MS004575
Analysis ID:AN004829
Instrument Name:Thermo Q Exactive Orbitrap
Instrument Type:Orbitrap
MS Type:ESI
MS Comments:MS acquisition: Xcalibur Targeted data processing: Xcalibur Untargeted data acquisition: Compound Discoverer, R studio
Ion Mode:UNSPECIFIED
  logo